Showing 2311-2320 of 2527 results for "".
- Zeiss and IDOC Partner to Bring Medical and Vision Care Products to Independent Optometrists Nationwidehttps://modernod.com/news/zeiss-and-idoc-partner-to-bring-medical-and-vision-care-products-to-independent-optometrists-nationwide/2476890/IDOC, Zeiss Vision Care US and Zeiss Medical Technology announced a 5-year agreement to bring Zeiss’ lab services, lens products and medical equipment to all 3,000+ IDOC independent optometrists across the United Stat
- Wills Eye Hospital Named #1 Ophthalmology Training Program In Americahttps://modernod.com/news/wills-eye-hospital-named-1-ophthalmology-training-program-in-america/2479536/Wills Eye Hospital has taken top honors again this year for the best residency training program in the United States for ophthalmologists. Doximity, which coordinates the vote, is the largest online physician network and is a navigator for medical students conside
- ProQR Receives Fast Track Designation from FDA for QR-1123 for Autosomal Dominant Retinitis Pigmentosahttps://modernod.com/news/proqr-receives-fast-track-designation-from-fda-for-qr-1123-for-autosomal-dominant-retinitis-pigmentosa/2479540/ProQR Therapeutics announced that it received fast track designation from the FDA for QR-1123, a first-in-class investigational antisense oligonucleotide designed to address the underlying cause of vision loss associated with autosomal dominant retinitis pigmentosa (adRP) due to the P23H mutation
- MST Innovations Introduces the Scleral IOL Fixation Solutions Packhttps://modernod.com/news/mst-innovations-introduces-the-scleral-iol-fixation-solutions-pack/2476857/MicroSurgical Technology has introduced the Scleral IOL Fixation Solutions Pack, which is designed to streamline the double-needle scleral IOL fixation technique with several unique new instruments that are conveniently packaged to support the procedure end-to-end. The comprehensive offeri
- EyeCare Partners Completes Acquisition of Associated Retinal Consultantshttps://modernod.com/news/eyecare-partners-completes-acquisition-of-associated-retinal-consultants/2476858/EyeCare Partners announced it has completed the acquisition of Associated Retinal Consultants, an ophthalmology provider and one of the largest retina subspecialty practices in the United States. Financial terms of the private transaction were not disclosed. Headquartered in
- iSTAR Medical Announces EUR 40 Million Series C Financinghttps://modernod.com/news/istar-medical-announces-eur-40-million-series-c-financing/2479542/iSTAR Medical announced the completion of a €40m Series C financing to support the development of iSTAR Medical’s MINIject device along the path to commercialization in Europe and the United States. MINIject, an ab-interno MIGS device, provides a powerful and reliable sol
- OD-OS to Showcase Navilas Navigated Retinal Laser Therapy at EURETINAhttps://modernod.com/news/od-os-to-showcase-navilas-navigated-retinal-laser-therapy-at-euretina/2476852/OD-OS will share clinical experiences with the Navilas 577s digital treatment platform this week at the EURETINA Congress in Paris. Navigated retinal laser therapy with the Navilas 577s allows for panretinal photocoagulation with uniform spot distribution, which is faster and less painful for pat
- Alimera Sciences Launches Iluvien in Germany For Noninfectious Uveitishttps://modernod.com/news/alimera-sciences-launches-iluvien-in-germany-for-noninfectious-uveitis/2476846/Alimera Sciences announced that it will immediately commence the launch of Iluvien in Germany for the prevention of relapse in recurrent noninfectious uveitis affecting the posterior segment of the eye (NIPU). Following the European Union’s Mutual Recognition Procedure in March 2019, Germany is t
- Horus Pharma Launches Neovis Total Multi for Dry Eye in New Sizehttps://modernod.com/news/horus-pharma-launches-neovis-total-multi-for-dry-eye-in-new-size/2476843/Horus Pharma announced the launch of a new 15ml bottle of Neovis Total Multi for the French, Belgian, and Spanish markets. The product is prescribed as third-line therapy for the treatment of dry eyes with keratitis or dry keratoconjunctivitis, following unsuccessful treatment with low-viscosity
- Japan Conducts World’s First Transplant With iPS Cells for Corneal Diseasehttps://modernod.com/news/japan-conducts-worlds-1st-transplant-with-ips-cells-for-corneal-disease/2476836/A research team from Japan’s Osaka University said Thursday that it has conducted the world’s first transplant for corneal disease using induced pluripotent stem (iPS) cells. The team conducted the surgery in July, allowing iPS corneal tissues to replace the current queuing for cornea